18.79
전일 마감가:
$18.87
열려 있는:
$18.78
하루 거래량:
153.43K
Relative Volume:
0.29
시가총액:
$5.13B
수익:
$1.40B
순이익/손실:
$164.00M
주가수익비율:
31.27
EPS:
0.6009
순현금흐름:
$-11.09M
1주 성능:
+4.56%
1개월 성능:
+6.10%
6개월 성능:
-14.98%
1년 성능:
-14.28%
Stevanato Group Spa Stock (STVN) Company Profile
Compare STVN vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
STVN
Stevanato Group Spa
|
18.79 | 5.15B | 1.40B | 164.00M | -11.09M | 0.6009 |
|
ISRG
Intuitive Surgical Inc
|
402.30 | 146.01B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
144.43 | 40.04B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
64.28 | 32.04B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
33.19 | 30.23B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
182.82 | 27.04B | 5.54B | 1.52B | 1.74B | 10.37 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-12-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-04-22 | 개시 | Exane BNP Paribas | Outperform |
| 2023-11-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-09-26 | 개시 | Stephens | Overweight |
| 2023-09-19 | 개시 | CJS Securities | Market Outperform |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-10 | 개시 | BofA Securities | Buy |
| 2021-08-10 | 개시 | Citigroup | Buy |
| 2021-08-10 | 개시 | Jefferies | Buy |
| 2021-08-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2021-08-10 | 개시 | Morgan Stanley | Overweight |
| 2021-08-10 | 개시 | Wells Fargo | Overweight |
모두보기
Stevanato Group Spa 주식(STVN)의 최신 뉴스
Wolfe Research initiates Stevanato stock with Outperform rating By Investing.com - Investing.com Australia
Wolfe Research initiates Stevanato stock with Outperform rating - Investing.com
Stevanato Group S.p.A. (STVN) Stock Analysis: An Under-the-Radar Healthcare Gem with 33% Upside Potential - DirectorsTalk Interviews
Stevanato’s GLP-1 Tailwinds Meet A Guidance Reality Check - Finimize
(STVN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking a Potential 37.89% Upside in the Healthcare Sector - DirectorsTalk Interviews
Stevanato maintains 2026 guidance of €1.260B-€1.290B revenue as it targets RTU cartridge production in early 2027 - MSN
Stevanato Group's Valuation Adjustment Signals Improved Financial Health and Market Position - Markets Mojo
Top Stevanato Group (STVN) Competitors 2026 - MarketBeat
Stevanato Group Earnings Call Highlights Growth and Strain - TipRanks
Stevanato Group Posts Strong Q1 2026 Growth and Accelerates Cartridge Capacity Expansion - TipRanks
Stevanato Group S.p.A. (STVN) Stock Analysis: A 38% Potential Upside Draws Investor Attention - DirectorsTalk Interviews
Liquidity Mapping Around (STVN) Price Events - Stock Traders Daily
Stevanato Group S.p.A. Ordinary Shares (NY: STVN - The Chronicle-Journal
Stevanato Group (NYSE: STVN) posts Q1 2026 growth and reaffirms 2026 outlook - Stock Titan
Baron entities (STVN) report 2.5M shares, 5.03% beneficial ownership - Stock Titan
T. Rowe Price holds 6.5% of Stevanato Group (STVN) in amended 13G/A - Stock Titan
Earnings call transcript: Stevanato Group Q1 2026 meets EPS, stock dips - Investing.com Nigeria
Earnings call transcript: Stevanato Group Q1 2026 meets EPS, stock dips By Investing.com - Investing.com South Africa
Transcript : Stevanato Group S.p.A. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08 - marketscreener.com
Stevanato Group Calls May 26, 2026 Teleconference Shareholders’ Meeting to Approve 2025 Results and Board Slate - The Globe and Mail
STVN SEC FilingsStevanato Group S P A 10-K, 10-Q, 8-K Forms - Stock Titan
Stevanato Group releases reports and shareholder meeting notice in SEC filing - Investing.com Australia
Stevanato Group releases reports and shareholder meeting notice in SEC filing By Investing.com - Investing.com South Africa
Ampoules Packaging Market (2026) | Glass & Plastic Packaging & - openPR.com
Stevanato Group S.p.A. (STVN) Stock Analysis: Healthcare Innovator with 36% Potential Upside - DirectorsTalk Interviews
Number of shareholders of Stevanato Group SpA – FWB:87N - TradingView
Stevanato Group (NYSE:STVN) Margin Uptick Tests Bullish Earnings Narrative After Q1 2026 Results - Sahm
Earnings Beat: Stevanato Group S.p.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Stevanato Group S.p.A. (NYSE:STVN) Q1 2026 Earnings Call Transcript - Insider Monkey
Stevanato Group Earnings Call: Growth With Constraints - TipRanks
Stevanato Group (NYSE:STVN) Issues Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Stevanato (STVN) Q1 2026 Earnings Transcript - AOL.com
Stevanato Group S.p.A. Q1 2026 Earnings Call Summary - Yahoo Finance
Stevanato Group Q1 2026 presentation: GLP-1s fuel 10% revenue gain - Investing.com Australia
Stevanato Group Q1 2026 presentation: GLP-1s fuel 10% revenue gain By Investing.com - Investing.com South Africa
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026 - The National Law Review
Stevanato Group Files Form 6-K Detailing Q1 2026 Results Presentation - TipRanks
Stevanato Group Files First-Quarter 2026 Interim Report Highlighting Risk Landscape - TipRanks
Stevanato Group Posts Q1 2026 Revenue Growth and Reaffirms Full-Year Guidance - TipRanks
Stevanato Group (STVN) posts higher Q1 2026 profit and strong cash flow - Stock Titan
Stevanato Group (NYSE: STVN) posts Q1 2026 growth and keeps 2026 outlook - Stock Titan
Stevanato Group (NYSE: STVN) posts 7% Q1 growth, keeps 2026 outlook - Stock Titan
Earnings call transcript: Stevanato Group Q1 2026 revenue beats forecast, stock dips - Investing.com Canada
Earnings call transcript: Stevanato Group Q1 2026 revenue beats forecast, stock dips By Investing.com - Investing.com South Africa
Stevanato Group S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Stevanato Group Spa (STVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):